These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1529671)

  • 21. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
    Sakai K
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of a dihydrofolate reductase gene mutation in methotrexate-resistant Drosophila cells.
    Hao H; Tyshenko MG; Walker VK
    Gene Expr; 1996; 6(4):231-9. PubMed ID: 9196078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
    Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
    Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase.
    Kamen BA; Whyte-Bauer W; Bertino JR
    Biochem Pharmacol; 1983 Jun; 32(12):1837-41. PubMed ID: 6882460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
    Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y
    Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate].
    Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA
    Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle-dependent DHFR and t-PA production in cotransfected, MTX-amplified CHO cells revealed by dual-laser flow cytometry.
    Kubbies M; Stockinger H
    Exp Cell Res; 1990 Jun; 188(2):267-71. PubMed ID: 2110526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired drug uptake in methotrexate resistant Crithidia fasciculata without changes in dihydrofolate reductase activity or gene amplification.
    Dewes H; Ostergaard HL; Simpson L
    Mol Biochem Parasitol; 1986 May; 19(2):149-61. PubMed ID: 3724795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of resistance to antifolates, a review.
    Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
    Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate-resistant human promyelocytic leukemia (HL-60) cells express a dihydrofolate reductase with altered properties associated with increased enzyme activity.
    Dedhar S; Goldie JH
    Biochem Biophys Res Commun; 1985 Jun; 129(2):536-45. PubMed ID: 3860203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
    Cowan KH; Goldsmith ME; Ricciardone MD; Levine R; Rubalcaba E; Jolivet J
    Mol Pharmacol; 1986 Jul; 30(1):69-76. PubMed ID: 3724746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line.
    Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S
    Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
    Affleck JG; Nowickyj SM; Walker VK
    Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single point mutation in Drosophila dihydrofolate reductase confers methotrexate resistance to a transgenic CHO cell line.
    Neumann K; Al-Batayneh KM; Kuiper MJ; Parsons-Sheldrake J; Tyshenko MG; Flintoff WF; Cole SP; Walker VK
    Genome; 2003 Aug; 46(4):707-15. PubMed ID: 12897877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate-based PROTACs as DHFR-specific chemical probes.
    Rana S; Dranchak P; Dahlin JL; Lamy L; Li W; Oliphant E; Shrimp JH; Rajacharya GH; Tharakan R; Holland DO; Whitten AS; Wilson KM; Singh PK; Durum SK; Tao D; Rai G; Inglese J
    Cell Chem Biol; 2024 Feb; 31(2):221-233.e14. PubMed ID: 37875111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia.
    Sweeney CL; Diers MD; Frandsen JL; Gunther R; Verfaillie CM; McIvor RS
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1075-84. PubMed ID: 11861818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine erythroleukemia cell variants: isolation of cells that have amplified the dihydrofolate reductase gene and retained the ability to be induced to differentiate.
    Corin RE; Turner T; Szabo P
    Biochemistry; 1986 Jul; 25(13):3768-73. PubMed ID: 3461851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
    James RI; May C; Vagt MD; Studebaker R; McIvor RS
    Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.